Management of anaplastic thyroid cancer
- PMID: 25713779
- PMCID: PMC4321056
- DOI: 10.3978/j.issn.2227-684X.2014.12.02
Management of anaplastic thyroid cancer
Abstract
Anaplastic thyroid cancer (ATC) is a deadly disease with a dismal prognosis. Molecular analyses of ATC tumors have yielded interesting results, which could help in understanding the underlying mechanisms of this aggressive disease process. Managing ATC can be challenging and includes rapid diagnosis, adequate staging, and interdisciplinary, multimodal treatments to optimize patient outcome. Treatments include surgical resection to gross negative margins when possible, as well as neo- or adjuvant treatment with chemotherapy or external beam radiation (XRT) for locoregional disease. New treatment strategies include evaluating the benefits of vascular disrupting agents and tyrosine kinase inhibitors for advanced ATC with driver mutations, which can be targeted. This review summarizes key concepts in managing ATC.
Keywords: Anaplastic thyroid cancer (ATC); diagnosis; prognosis; surgery; treatment.
Figures



References
-
- Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005;103:1330-5. - PubMed
-
- Kebebew E.Anaplastic thyroid cancer: rare, fatal, and neglected. Surgery 2012;152:1088-9. - PubMed
-
- Bronner MP, LiVolsi VA. Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol 1991;4:637-43. - PubMed
-
- Gaffey MJ, Lack EE, Christ ML, et al. Anaplastic thyroid carcinoma with osteoclast-like giant cells. A clinicopathologic, immunohistochemical, and ultrastructural study. Am J Surg Pathol 1991;15:160-8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical
Research Materials